SELLAS Life Sciences Group, Inc. (SLS)

USD 0.84

(-4.62%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - 1 Million 7.6 Million 1.9 Million - -
Cost of Revenue - 100 Thousand 200 Thousand - - -
Gross Profit - 900 Thousand 7.4 Million 1.9 Million - -
Operating Expenses 37.86 Million 42.85 Million 32.69 Million 18.88 Million 17.2 Million 31.08 Million
Selling, General and Administrative Expenses 13.86 Million 12.58 Million 11.32 Million 9.6 Million 9.92 Million 12.77 Million
Research and Development Expenses 24 Million 30.26 Million 21.37 Million 9.28 Million 7.28 Million 18.31 Million
Other Expenses - 10 Million 5.7 Million - - -3.03 Million
Cost and Expenses 37.86 Million 42.95 Million 32.89 Million 18.88 Million 17.2 Million 31.08 Million
Operating Income -37.86 Million -41.95 Million -25.29 Million -16.98 Million -20.04 Million -31.08 Million
Interest Expense - - - - 118 Thousand 266 Thousand
Income Tax Expense - -649 Thousand -237 Thousand -17 Thousand -81 Thousand -1.37 Million
Earnings before Tax -37.34 Million -41.3 Million -20.93 Million -16.77 Million -19.37 Million -29.04 Million
Net Income -37.34 Million -40.65 Million -20.69 Million -16.75 Million -19.29 Million -27.67 Million
Earnings Per Share Basic -1.34 -2.10 -1.34 -2.10 -7.54 -105.80
Earnings Per Share Diluted -1.34 -2.10 -1.34 -2.10 -7.54 -105.80
Weighted Average Shares Outstanding 27.77 Million 19.39 Million 15.48 Million 7.97 Million 2.55 Million 261.54 Thousand
Weighted Average Shares Outstanding (Diluted) 27.77 Million 19.39 Million 15.48 Million 7.97 Million 2.55 Million 261.54 Thousand
Gross Margin - 0.90 0.97 1.00 - -
EBIT Margin - -42.28 -3.90 -8.89 - -
Profit Margin - -40.65 -2.72 -8.82 - -
EBITDA 529 Thousand -31.95 Million -19.66 Million -16.39 Million 668 Thousand -
Earnings Before Tax Margin - -41.95 -3.33 -8.94 - -

Income Statement Charts